Biocon Q1 net profit rises 53% to Rs 136.8 crore

Biocon is a company that makes medicines.

It told everyone how much money it made in the first three months of its financial year.

The company made a bigger profit than it did at the same time last year.

Its profit went up by more than 53 percent.

The company earned more money mostly because its medicine business grew strongly.

Sales of biosimilars and generics, two kinds of medicines it sells, went up.

Its total income also increased compared to last year.

Even though the company also spent more money, it still ended up with a higher profit.

This means the company is doing well.